ABSTRACT
Objectives:
The primary objective of the study was to determine the potential tissue changes and ultrasound elastography flow rates at the sensitive points in patients with fibromyalgia syndrome and to obtain objective data; secondary aim is to determine the relationship between these flow rates and disease symptoms and quality of life and to determine the usefulness of these data in the follow-up of functional status and treatment of patients.
Materials and Methods:
Twenty-four female patients diagnosed as fibromyalgia syndrome with sensitive points in the upper trapezius and supraspinatus regions were questioned for morning stiffness, sleep quality, pain level (visual analog scale), mental status (Beck Depression Scale), functional status (Fibromyalgia Impact Questionnaire) and quality of life (SF-36). The ultrasound elastography flow velocities at the sensitive upper trapezoidal and supraspinatus points were measured with the Acuson S2000 ultrasound system (Siemens Medical Solutions, Mountain View, CA). All data were analysed statistically for correlation.
Results:
The mean age was 51.4 years (min-max=26-74). There was a positive correlation between ultrasound elastography flow rates and some SF-36 subscores and left trapezoidal neutral position and Visual Analogue Score (r=0.510, p=0.013).
Conclusion:
The data is not sufficient to use ultrasound elastography flow rates as a quantitative diagnostic criterion in fibromyalgia syndrome. Further studies involving enough sample size and including a control group will allow the questioning of the true value of the significant correlations that we find.
Keywords:
Fibromyalgia Syndrome, Shear-wave Elastography, Quality of Life
References
1Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum. 1990;33:160-172.
2Wolfe F, Brahler E, Hinz A, et all. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 2013;65:777-785.
3Fietta P, Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed. 2007;78:88-95.
4Dadabhoy D, Clauw DJ. Therapy Insight: fibromyalgia--a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol. 2006;2:364-372.
5Bengtsson A, Henriksson KG, Jorfeldt L, et al. Primary fibromyalgia: a clinical and laboratory study of 55 patients. Scand J Rheumatol. 1986;15:340-347.
6Wortmann RL. Searching for the cause of fibromyalgia: is there a defect in energy metabolism? Arthritis Rheum. 1994;37:790-793.
7Kurtaiş Aytür Y. Fibromiyalji Sendromu. Romatoloji e Book, http://www.trasdromatolojiekitap.org/icindekiler.php?id=85
8Gennisson JL, Deffieux T, Fink M, et al. Ultrasound elastography: principles and techniques. Diagn Interv Imaging. 2013;94:487-495.
9Wu CH, Chen WS, Park GY, et al. Musculoskeletal sonoelastography: a focused review of its diagnostic applications for evaluating tendons and fascia. J Med Ultrasound. 2012;20:79-86.
10Drakonaki EE, Allen GM, Wilson DJ. Ultrasound elastography for musculoskeletal applications. Br J Radiol. 2012;85:1435-1445.
11Ophir J, Alam SK, Garra BS, et al. Elastography: Imaging the elastic properties of soft tissues with ultrasound. J Med Ultrason. 2002;29:155.
12Genç A, Güneş S, Kutlay S. The Role of Ultrasound Elastography in Musculoskeletal Diseases. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2018;71:91-95.
13Taljanovic MS, Gimber LH, Becker GW, et al. Shear-Wave Elastography: Basic Physics and Musculoskeletal Applications. Radiographics. 2017;37:855-870.
14Beck AT, Ward CH, Mendelson M, et al. Beck Depression Inventory. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
15Ediz L, Hiz O, Toprak M. The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire. Clin Rheum. 2011;30:339-346.
16Bennett RM, Friend R, Jones KD, et al. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11:R120. Erratum in: Arthritis Res Ther. 2009;11:415.
17Ware JE Jr. SF-36 Health Survey update. Spine (Phila Pa 1976). 2000;15;25:3130-3139.
18Koçyiğit H, Aydemir Ö, Fişek G, et al. Kısa Form-36 (KF-36)’nın Türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç ve Tedavi Dergisi. 1999;12:102-106.
19Fitzcharles MA, Boulos P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford). 2003;42:263-267.
20Mease P, Arnold LM, Choy EH, et al. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009;36:2318-2329.
21Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005;75:6-21.
22Mease P, Arnold LM, Bennett R, et al. Fibromyalgia syndrome. J Rheumatol. 2007;34:1415-1425.
23Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600-610.
24Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46:319-329.
25Kraft GH, Johnson E, LaBan MM. The fibrositis syndrome. Arch Phys Med Rehabil. 1968;49:155-162.
26Awad EA: Interstitial myofi brositis: hypothesis of the mechanism. Arch Phys Med Rehab. 1973;54:449-453.
27Fischer A. Documentation of myofascial trigger points. Arch Phys Med Rehab. 1988; 69:286-291.
28Basford JR, An Kai-Nan. New Techniques for the Quantification of Fibromyalgia and Myofascial Pain. Current Pain & Headache Reports. 2009;13:376-378.
29Sikdar S, Shah JP, Gilliams E, et al. Assessment of myofascial trigger points (MTrPs): A new application of ultrasound imaging and vibration sonoelastography. Conf Proc IEEE Eng Med. Biol Soc 2008;2008:5585-5588.
30Muro-Culebras A, Cuesta-Vargas AI. Sono-myography and sono-myoelastography of the tender points of women with fibromyalgia. Ultrasound Med Biol. 2013;39:1951-1957.
